• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. TAPERLOC XR FP TYPE1 PPS; PROSTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. TAPERLOC XR FP TYPE1 PPS; PROSTHESIS, HIP Back to Search Results
Catalog Number 51-102080
Device Problem Device Contaminated During Manufacture or Shipping (2969)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/02/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Customer has indicated that the product is in the process of being returned to zimmer biomet for investigation.Once the investigation has been completed, a follow-up mdr will be submitted.Concomitant medical products: item# 51-101080/ tprlc 133 fp type1 pps ho /lot # 3751410, item# 51-104130/ tprlc 133 t1 pps ho/ lot # 2711291, item# 51-102070/tprlc xr fp type1 pps/ lot # 3429122, item# 51-107100/ tprlc 133 mp type1 pps ho/ lot # 3786480, item# 51-105090/ tprlc xr t1 pps/ lot # 3406165.Report source: (b)(6).Multiple mdr reports were filed for this event, please see associated reports: 0001825034-2020-02851, 0001825034-2020-02852, 0001825034-2020-02854, 0001825034-2020-02856, 0001825034-2020-02857.
 
Event Description
It was reported that during circulation of product in warehouse, debris was found in the sterile packaging.There was no patient involvement.Attempts have been made and additional information on the reported event is unavailable at this time.
 
Manufacturer Narrative
This follow-up report is being submitted to relay additional information.Complaint sample was evaluated and the reported event was confirmed.Evaluation of the returned product/photographs provided confirmed foreign debris is present inside the sterile packaging, and the sterile packaging remains sealed.Additional review found debris inside the sterile packaging which is consistent with the appearance of foam debris from the foam packaging inside the sterile barrier.Sterility has been compromised.Review of the device history records identified no deviations or anomalies during manufacturing related to the reported event.The root cause of the reported event is the operator not following the work instructions provided.The white foam debris is likely due to transit damage.The event is being further reviewed through the capa process.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
No further event information available at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TAPERLOC XR FP TYPE1 PPS
Type of Device
PROSTHESIS, HIP
Manufacturer (Section D)
ZIMMER BIOMET, INC.
56 e. bell drive
warsaw IN 46582
MDR Report Key10304995
MDR Text Key199892428
Report Number0001825034-2020-02855
Device Sequence Number1
Product Code LPH
Combination Product (y/n)N
PMA/PMN Number
K120030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 10/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number51-102080
Device Lot Number3751538
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/22/2020
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/02/2020
Initial Date FDA Received07/21/2020
Supplement Dates Manufacturer Received09/30/2020
Supplement Dates FDA Received10/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Treatment
SEE H10
-
-